Video & Transcript : 'treatment program' :

Page 106 of 500
NE
Transcript Highlights:
  • Whitehall Campus provides treatment through two programs.
  • Whitehall Campus provides treatment through two programs.
  • , safe and caring environments, nonlinear treatment gains, responsibility, and evidence-based programming
  • sure that all of our programs are receiving the level of care, treatment planning, and engagement that
  • But a residential treatment program is very different, so what it would take to bring that building up
Summary: The Health and Human Services Committee held an invited-testimony hearing on LR 425, which examines the Whitehall campus in Lincoln and possible long-term options for youth currently served there. Chair Brian Hardin explained that Whitehall houses two separate programs for adolescent males: a substance use program and a youth-who-sexually-harm program. Testimony from DHHS officials described Whitehall as a Joint Commission-accredited psychiatric residential treatment facility (PRTF) that provides about 40 hours of weekly programming, family involvement, school services, and community reintegration activities. Officials said the department is evaluating whether the programs should remain at Whitehall or move to another state-owned facility, with Hastings described as the department’s preferred alternative because it is more residential in design than a youth rehabilitation treatment center (YRTC).
NM

New Mexico 2026 Regular Session

House - Health and Human Services Jan 26th, 2026 at 09:05 am

House Health & Human Services

Transcript Highlights:
  • So it is a headhunter program.
  • The program is reaching now... I appreciate this bill. The program is reaching out.
  • residential treatment programs, adolescent detoxification facilities, and step-down facilities for youth
  • Short-term treatment.
  • The program, to me...
Keywords: 996, all
NH

New Hampshire 2026 Regular Session

Senate Health and Human Services (04/01/2026)

Health and Human Services

Transcript Highlights:
  • </c> treatment. 95%. treatment. 95%.
  • . treatment. treatment.
  • </c> for treatment options. for treatment options.
  • </c> and treatments. and treatments.
  • Now, that massive gap is why you can see that under these state programs sometimes, treatments are available
Keywords: 1191, senate, all
MA

Massachusetts 2025-2026 Regular Session

Public Health Effects of Xylazine Feb 9th, 2026

Transcript Highlights:
  • The error of inquiry, as a reminder, the availability of effective outreach and treatment programs for
  • and outreach programs and services.
  • and outreach programs and services.
  • Narcan and other treatments.
  • Two sections together on how we can increase the understanding of these outreach and treatment programs
Keywords: 1212, all
Summary: The special commission on xylazine met virtually, called to order by House Chair Mindy Domb, with a quorum present. The commission approved the minutes from its December 11 public meeting and then reviewed the first draft of its final report, which is due to the Legislature by March 30, 2026. Staff explained the report structure, including a commission overview, findings and recommendations from each working group, and appendices with meeting materials and public resources. Commissioners discussed the distinction between licit veterinary xylazine and illicit xylazine in the drug supply, noting that the illicit supply is generally not diverted from legal veterinary sources but obtained through online vendors, and they clarified that xylazine is already classified in Massachusetts as a Schedule 6 substance, so the policy question is whether additional scheduling or penalties are warranted. For the best practices and enforcement section, staff recommended stronger guidance on secure storage and recordkeeping for authorized users, better reporting of diversion, theft, and suspicious orders, and focused enforcement on illicit production and fentanyl trafficking rather than individual possession. Commissioners suggested adding coordination among public safety, law enforcement, and the Attorney General’s office, as well as a state-level approach to emerging drug threats. In the outreach and treatment section, the draft emphasized that existing harm reduction, wound care, naloxone, and mobile outreach programs are effective but need broader coordination, more trauma-informed care, and better education for providers and first responders. Commissioners raised concerns about provider familiarity with xylazine, the need for first responders to include fire personnel and EMS, and the importance of not turning away people with xylazine-related wounds from recovery or treatment settings. The education and training section identified four target audiences: first responders, clinicians, non-clinicians in treatment and outreach settings, and people who use drugs and their families. The draft recommended tailored, stigma-free training and educational materials for each group, with consistent updates, continuing education credits where appropriate, and better access to centralized, real-time data on xylazine and other emerging contaminants. Commissioners discussed the need for centralized reporting and public health surveillance, including existing tools like the BSAS dashboard and StreetCheck, and several members urged the commission to recommend a DPH task force or similar body to monitor future drug supply threats. The meeting ended with staff outlining next steps: a revised draft would be circulated by the end of the week, feedback would be incorporated into a second draft by March 2, and the commission planned to vote on the final report at its March 9 meeting, with a backup meeting later in March if needed.
MN

Minnesota 2025-2026 Regular Session

Committee on State and Local Government - 03/18/25

State and Local Government

Transcript Highlights:
  • Senate File 1858 is the Market Bucks program.
  • </c> programs and and people really enjoy it. programs and and people really enjoy it.
  • </c><00:19:08.960><c> One</c> Direct care and treatment as a standalone agency.
  • Direct care and treatment has 5,000 employees.
  • ,</c><00:23:06.320><c> uh,</c> Services, direct care and treatment, uh, Services, direct care and treatment
Keywords: 1187, senate, all
TX

Texas 89th Regular

Corrections Apr 30th, 2025 at 08:04 am

Corrections

Transcript Highlights:
  • and supervision program.
  • and supervision program.
  • Also, are there special kinds of treatment programs that you would get at TCCO that you wouldn't get
  • program, and their program actually dovetails into our program so that the individuals who are civilly
  • program.
Summary: The Corrections Committee first took up pending business and reported several previously heard bills favorably to the full House, including HB 1515 and SB 2405, the TDCJ Sunset bill and its Senate companion, HB 5639 on the veteran housing program, HB 2854 on hospital visits as a parole or mandatory supervision condition and related hospital liability, and SB 1080 on occupational licenses for people with criminal convictions. The committee also heard and advanced SB 1080 without amendment, then moved into new business. A major portion of the meeting focused on HB 3618, which would limit invasive group strip searches of female inmates in TDCJ facilities. Formerly incarcerated women and advocates testified in support, describing humiliation, trauma, barriers to programming, and arguing that searches were often ineffective and that contraband more often comes from staff. TDCJ’s resource witness said the agency has looked at technology such as millimeter scanners and is in the process of placing them in facilities, while the bill sponsor said the measure would preserve searches in emergencies and require female officers when women are unclothed. HB 3618 was left pending. The committee also heard HB 4515 on expanding orders of nondisclosure, with the author saying the committee substitute would narrow the bill to marijuana possession only; supporters from Alliance for Safety and Justice and Right on Crime argued it would improve reentry and public safety, while members asked about eligibility and related offenses. HB 1826, requiring depression screenings for pregnant and postpartum incarcerated women, drew support from women’s health advocates and formerly incarcerated witnesses; the bill was left pending. HB 1969, to help people leaving prison renew or obtain driver’s licenses, and HB 2708, expanding nondisclosure eligibility for certain misdemeanor convictions, were also laid out and left pending. Later, the committee heard HB 2729, which would bar hearsay evidence in hearings on violations of release conditions, and SB 1021, which would make stalking convictions ineligible for community supervision and add related victim-protection provisions; both were left pending. SB 1610, addressing civil commitment facility safety, sex offender registration, and penalties for assaults on staff, drew strong opposition from civil commitment residents, family members, and civil rights advocates who argued it was punitive and raised due process concerns; the resource witness said assaults had increased and explained the civil commitment process and existing legal safeguards. Finally, HB 4764 would require TDCJ to report detailed annual data on restrictive housing; supporters said the bill would improve transparency around solitary confinement, and the committee left it pending before adjourning.
MN

Minnesota 2025-2026 Regular Session

Committee on Human Services - 01/27/25

Human Services

Transcript Highlights:
  • , where you have a program that is tasked with having a treatment program for individuals who have been
  • , where you have a program that is tasked with having a treatment program for individuals who have been
  • , where you have a program that is tasked with having a treatment program for individuals who have been
  • , where you have a program that is tasked with having a treatment program for individuals who have been
  • /c><00:50:23.160><c> for</c> with uh having a treatment program for with uh having a treatment program
Keywords: 1187, senate, all
MA

Massachusetts 2025-2026 Regular Session

Public Health Effects of Xylazine Feb 9th, 2026

Transcript Highlights:
  • The error of inquiry, as a reminder, the availability of effective outreach and treatment programs for
  • and outreach programs and services.
  • The area of inquiry, as a reminder, the availability of effective outreach and treatment programs for
  • and outreach programs and services.
  • Narcan and other treatments.
Summary: The Special Commission on xylazine convened a public meeting to review and discuss the first draft of its final report, approve prior minutes, and gather feedback for revisions. The commission first approved the December 11 minutes by roll call vote, then reviewed the report structure, which will include a commission overview, working group findings and recommendations, and appendices with public meeting materials and public resources. Staff explained the report’s framing of xylazine as both a licensed veterinary drug and an illicit drug supply contaminant, and members discussed the distinction between legal animal use and illicit importation/adulteration, with several commissioners emphasizing that people who use drugs do not intentionally seek xylazine. The commission then walked through draft findings and recommendations for best practices in oversight and enforcement, outreach and treatment, and education and training. Members discussed whether xylazine should be further scheduled or instead addressed through other public health and enforcement measures, with the draft leaning toward maintaining the current Schedule 6 status while strengthening public health responses, surveillance, drug checking, and targeted enforcement against illicit production and distribution. Commissioners also proposed stronger coordination among public safety, law enforcement, and public health, including real-time alerts, centralized data sharing, and possibly a DPH task force on emerging drug supply threats. The outreach and treatment section focused on existing harm reduction, wound care, naloxone, and mobile/low-threshold services, while noting gaps such as lack of an FDA-approved human reversal agent, geographic access barriers, insurance issues, and limited provider familiarity. A substantial portion of the meeting focused on education and training for first responders, clinicians, non-clinicians, and people who use drugs and their families. Commissioners supported tailored, stigma-free materials that cover xylazine basics, signs and symptoms, wound care, withdrawal, harm reduction, and when to seek medical care, with repeated emphasis on including firefighters, EMS, law enforcement, and other first responders in definitions and training. Members also stressed the need for consistent, centralized, and up-to-date public health data, better communication of emerging contaminants beyond xylazine, and practical guidance to prevent people with xylazine-related wounds from being turned away from care or recovery settings. The meeting ended with agreement to incorporate the feedback into a revised draft to be circulated by March 2, with another meeting scheduled for March 9 and a backup meeting later in March if needed; the commission then adjourned by unanimous motion.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 10:00 am

Joint Committee on Financial Services

Transcript Highlights:
  • , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
  • , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
  • The next step was radioactive iodine treatment, which is where biomarkers come into my treatment plan
  • Such programs typically cost more in the short term than a skilled nursing-based program, but if they
  • Such programs typically cost more in the short term than a skilled nursing-based program, but if they
Keywords: 995, all
Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.
MA
Transcript Highlights:
  • Effective outreach and treatment programs for patients who have been exposed to xylazine and ways to
  • address any gaps that might exist in available outreach and treatment programs and services.
  • programs.
  • You know, often we see harm reduction outreach programs that do have some wound care treatment, but some
  • That's a critical part of, I think, both treatment models and outreach and harm reduction programs: making
Keywords: 995, all
Summary: The Working Group on Outreach and Treatment of the Special Commission on Xylazine held its first meeting, chaired by Gabe Adams-Cain in Senator John Villis’s absence. Members introduced themselves and described priorities such as improving education about xylazine, expanding first responder and clinical training, and ensuring patients and providers know how to respond to xylazine-related wounds and complications. Several participants emphasized that outreach should reach both people who have not been exposed and those already affected, and that stigma is a major barrier for patients and families. Discussion focused on the main challenges to treatment and outreach, including limited awareness, inconsistent wound care access, gaps in geographic coverage, cost of supplies, and the need for better training in both outpatient and inpatient settings. Dr. Kimmel noted that harm reduction and outreach programs are already providing much of the care, but often lack specialized staff, sufficient supplies, and standardized protocols. He also said xylazine can complicate withdrawal and make it harder for people to engage in substance use treatment. Members discussed the value of non-stigmatizing, consensus messaging, family support organizations, and existing resources such as PARI, StreetCheck, and state-funded syringe service and naloxone networks. The group also reviewed the commission timeline and next steps. Staff said materials for the December 11 full commission meeting should be submitted by December 2, with draft presentation materials to be shared by December 4 and reviewed by December 9. Members agreed to do additional follow-up research on topics including the cost-effectiveness and contents of self-care wound kits, outreach to family and recovery organizations, incarcerated populations, and geographic access gaps. The meeting ended with agreement to use a PowerPoint-style presentation and to continue compiling research through a shared folder, followed by adjournment at 9:55 a.m.
NM
Transcript Highlights:
  • So, the Health Care Authority was authorized by the Federal Medicaid Waiver Program, or 1115 Waiver Program
  • And the third will be treatment courts.
  • And does this program really work? So, Mr.
  • us on treatment.
  • It is not a permanent program.
KY
Transcript Highlights:
  • . programs. programs.
  • Programs offered.
  • Programs<00:19:13.679><c> offered.</c> Programs offered. Programs offered.
  • > for</c> treatment treatment vouchers uh for treatment treatment vouchers uh for those<00:52:32.160>
  • We have so much treatment in treatment.
Keywords: 958, all
Summary: The subcommittee first heard from the Justice and Public Safety Cabinet’s Grants Management Division on federal victim-services funding. Staff described the main grant programs they administer, including STOP VAWA, VOCA victim assistance, sexual assault services, Byrne state crisis intervention, and Project Safe Neighborhoods. They emphasized that VOCA is especially volatile because it is funded by the federal Crime Victims Fund, which has declined sharply in recent years, reducing Kentucky’s available awards and forcing cuts to state, local, and nonprofit subgrants. They also outlined steps the cabinet has taken to stabilize funding, including changing the subaward formula, aligning the grant period with the state fiscal year, subawarding one year behind the federal cycle, and retaining a reserve. Members asked about how funds reach victims, how subgrantee amounts are determined, and requested a breakdown of grant recipients and amounts; staff said they would provide that information later. The committee then received a detailed presentation from the Department of Juvenile Justice on alternatives to detention. Commissioner Randy White and staff explained that ATDs are short-term, less restrictive placements for low-risk youth, including electronic monitoring, home supervision, group homes, foster care, private child care, community programs, mentoring, evening reporting centers, and in-home wraparound services. They described the referral and approval process involving court-designated workers, detention alternative coordinators, courts, and county attorneys, and said DJJ currently has 16 ATD-related contracts, with placements, programs, and electronic monitoring among them. They also reported that between July 1, 2024, and July 30, 2025, 1,652 juveniles were involved in the process, including 168 diversion cases. Members questioned the cost of juvenile detention versus adult incarceration, whether families pay for electronic monitoring, whether there is a national model for juvenile detention, and what alternatives exist for truancy and contempt cases. DJJ said families do not generally reimburse for electronic monitoring, there is no single national model, and day treatment centers are an important alternative for some youth. The department also said it builds daily routines and wellness education into its facilities, and that more than two-thirds of its programs are evidence-based. Officials said they currently monitor vendor performance through quarterly reviews and can end contracts for poor performance, but that data tracking is still largely manual. They said the new JCOM system, now in pilot in the eastern region, should improve reporting and help identify outcomes and recidivism more effectively.
ID

Idaho 2026 Regular Session

Agenda Jan 28th, 2026

Transcript Highlights:
  • We are looking at how many folks we can serve with those treatment programs.
  • The program that we intended to put together for that was a treatment court program.
  • I want to follow up on Representative, Senator Winchow's comments pertaining to your treatment program
  • Without that treatment program for the individuals who are getting that service, what...
  • Without that treatment program for the individuals who are getting that service, what does the outcome
Keywords: 989, all
Summary: A joint Senate Finance and House Appropriations committee heard presentations on the Idaho judicial branch budget, beginning with court operations. Legislative staff reviewed the branch’s structure, staffing, recent technology upgrades funded with ARPA dollars, and prior budget enhancements, including support for court technology, judicial compensation, and additional judges in several districts. Court officials explained a late budget request for an additional $800,700 from a dedicated magistrate retirement fund to cover unexpected retirement bonuses and purchase-of-service costs for seven magistrates, as well as the impact of a governor holdback and reduced federal support for some treatment and domestic violence court-related services. Committee members asked about the timing of the revised retirement request, the purpose and success of the magistrate retirement bonus program, the court’s technology modernization, and the effect of losing federal and other outside funding. Court officials said the retirement timing could not be known earlier because magistrates had until January to notify the court, and they described the bonus as helping judges complete their terms. They also said the court had moved case management and recording systems to the cloud and built a statewide network, and that cuts to treatment court and peer support funding would likely force reductions in non-constitutional services. The committee then heard the Guardian ad litem division request, including a $77,900 general fund enhancement for the Second Judicial District CASA program. The CASA director said the money would support a recruiter/trainer/data supervisor position and required compliance costs such as financial review, office space, and liability insurance. She described volunteer shortages across a large rural district, declining VOCA and grant funding, and the need to spend more time fundraising instead of serving children. Members asked about the decline in VOCA funds, the share of funding coming from donations and fundraising, the number of children served, and the role of CASA for older youth. The director said about 30% of the program’s funding comes from fundraising, that the district serves children over age 12 and some older youth, and she gave an example of a case where CASA helped stabilize a family and reunify children with their parents. No votes were taken, and the committee adjourned until the next day.
NM

New Mexico 2025 Regular Session

IC - Legislative Health and Human Services Oct 8th, 2025

Legislative Health & Human Services Committee

Transcript Highlights:
  • Third, improving access to comprehensive treatment by revising state opioid treatment program regulatory
  • Page 3, my question is regarding the treatment program locations.
  • Are these outpatient treatment program locations?
  • Madam Chair, Representative Chavez, the map indicates the locations of opioid treatment programs, also
  • It's not restricted to an opioid treatment program, which is a specialty facility.
TX

Texas 89th Regular

Corrections Mar 12th, 2025

Corrections

Transcript Highlights:
  • In addition to that, we have structured treatment programs within TDCJ for substance use.
  • We have the substance abuse treatment program we can utilize.
  • The tiered program is based on individual progress and treatment.
  • This slide gives some overview of our treatment program.
  • We offer six hours of group treatment programming every week.
Keywords: 1184, house, all
MA
Transcript Highlights:
  • We have OTPs through all of our facilities with opioid treatment programs and medication-assisted treatment
  • Behavioral health, mental health, substance use, and other treatments: 415 programs spread throughout
  • program.
  • Worcester substance abuse treatment opportunity program, their STOP program.
  • In 2023, Worcester County Sheriff's Office introduced the Substance Treatment Opportunity Program, called
Keywords: 995, all
Summary: The meeting was the third public session of the Special Commission on Correctional Consolidation and Collaboration. Members introduced themselves, and the commission approved the prior meeting minutes. The main presentation came from the Massachusetts Sheriffs’ Association, led by several sheriffs, who described the role of sheriffs’ offices as independently elected county institutions that operate jails and houses of correction, regional lockups, civil process, 911 communications in some counties, school resource officers, and investigative units. They emphasized that most of their population is pretrial, that admissions and releases are far higher than the Department of Correction’s, and that their facilities now house more people overall than DOC despite having a smaller budget. The sheriffs argued that their work has shifted toward rehabilitation, reentry, and public health, highlighting extensive programming in mental health, substance use treatment, medication-assisted treatment, education, vocational training, and gender-specific, trauma-informed services. They said standardized risk/needs assessments and better funding would help make services more consistent across counties. They also described specialized units and models such as regional evaluation and stabilization units, older-adult housing, emerging adult and gang-intervention programs, and reentry centers that connect people to housing, employment, family support, and community services. Several examples were cited, including Suffolk’s Project Evolve, Middlesex’s older-adult unit, Hampden’s MAGIC program, Worcester’s STOP program, and county reentry centers across the state. A major theme was that these programs are expensive but, in the sheriffs’ view, reduce recidivism and improve safety by stabilizing people before release and supporting them afterward. They pointed to COVID-19 as a period when sheriffs adapted facilities for quarantine and medical care, and said they continue to work with public health partners. They also stressed that their facilities are heavily audited by state and federal agencies and that maintaining humane, safe conditions requires significant staffing and operating costs. Commission members responded favorably at points, noting the importance of the turnover in sheriff populations and the need to understand the different correctional mission compared with DOC. The meeting ended with discussion of future commission dates and a note that the presentation materials would be shared electronically.
MN
Transcript Highlights:
  • This reduces the time for an opioid treatment program to complete an individual treatment plan from 21
  • opioid treatment program.
  • This adds some SUD treatment program client record requirements.
  • This reduces the time for an opioid treatment program to complete an individual treatment plan from 21
  • opioid treatment program.
Keywords: 1187, senate, all
CA

California 2025-2026 Regular Session

Assembly Health Committee Apr 21st, 2026

Transcript Highlights:
  • Connect, a Los Angeles-based program that links residents to curative hepatitis C treatment.
  • Under current law, treatment programs and facilities receiving public funds and narcotic treatment programs
  • , except for the previously mentioned narcotic treatment programs.
  • Public programs are required to contribute data that informs treatment efficacy, need adequacy, and funding
  • Public programs are required to contribute data that informs treatment efficacy, need adequacy, and funding
Summary: The Assembly Health Committee heard a long agenda of health-related bills, with most items presented for later vote once quorum was reached. Early in the hearing, the committee adopted a consent calendar of multiple bills with motions for due pass to Appropriations, and it noted that AB 2029 had been pulled from the agenda. The committee also took up AB 1973, a bill by Aguiar-Curry to expand who may provide procedural abortion care. Supporters, including physicians and certified nurse midwives, argued the bill would align law with current training and improve access, while opponents said later-term abortion procedures require physician-level surgical training and raised safety concerns. The author emphasized hands-on training, consultation, and transfer protocols, and the bill was held pending quorum with a motion and second recorded. The committee then heard AB 1558 by Arambula, which would adopt the Uniform Emergency Volunteer Health Practitioners Act to speed the use of out-of-state licensed volunteers during declared disasters. Supporters from the Uniform Law Commission and the Red Cross said the bill would reduce delays and clarify legal authority for volunteer health workers; there was no opposition testimony. AB 2282 by Alanis, a temporary rural emergency stabilization center for Patterson while a permanent hospital is built, drew support from local emergency responders and a late opposition from the California chapter of ACEP. The chair praised the bill as a creative local solution and agreed to coauthor it; a motion and second were recorded, with the vote to occur later. Several public health access bills followed. AB 1843 by El-Hawari would limit prior authorization and align hepatitis C treatment coverage with medical guidelines; supporters said it would remove barriers to a curable disease, while health plans opposed it as a mandate, citing premium impacts and the recent SB 306 prior-authorization process. AB 2247 by El-Hawari would create the THRIVE program for mental health services for youth affected by gun violence; Youth Alive and other supporters described trauma-informed, community-based care, and the chair and another member asked to be added as coauthors. AB 2138 by Krell would expand access to certified peer support specialists in enhanced care management and remove automatic disqualifications based solely on criminal history; supporters said peers are essential to engagement and recovery, and the bill was held with a motion and second. Later, AB 1682 by Hart would require coverage of scalp cooling for chemotherapy patients, with emotional testimony from cancer survivors and clinicians; insurers opposed it as another mandate, but the author stressed the modest per-member cost and the bill was moved with a motion and second. AB 1879 by Dixon would standardize data reporting for alcohol and drug treatment facilities, including private providers, to improve statewide information on outcomes and access; the bill drew broad support from recovery organizations and the prior opposition was withdrawn after amendments. AB 1906 by Aguiar-Curry would require coverage of at-home cervical cancer screening kits without cost sharing; supporters cited improved access for rural and working Californians, insurers opposed it on affordability grounds, and the bill passed on a recorded roll call after quorum was established. Finally, AB 1556 by Haney would clarify and support drug-free recovery housing and return-to-use policies; supporters said it would expand sober housing options, while opponents warned it could allow evictions after relapse and conflict with Housing First principles. The hearing ended with the bill still under discussion and opposition-unless-amended concerns noted.
CA

California 2025-2026 Regular Session

Senate Health Committee Jul 1st, 2026

Transcript Highlights:
  • Treatments that are planned treatments entitled to under their existing health benefits, treatments that
  • of treatment is, so if the course of treatment is something that it needs to be checked in on earlier
  • Among those who go without care, 39% do not know where to find treatment and 36% cannot find a program
  • Among those who go without care, 39% do not know where to find treatment and 36% cannot find a program
  • . ...know where to find treatment and 36% cannot find a program that meets their needs.
Summary: The committee heard AB 1887, which would speed prior authorization for FDA-approved rare disease treatments prescribed by specialists and, if a plan does not act within 30 days, deem the request approved. The author and supporters, including patients and clinicians, said delays can cause irreversible harm, hospitalizations, and death, especially for children and people with progressive rare diseases. Health plans and insurers opposed the bill’s automatic-approval provision and said the measure lacked safeguards for incomplete requests and shared responsibility for timely information. The chair encouraged continued work with opponents, and the author said the bill was narrowed from an earlier version that would have waived prior authorization entirely. The committee also heard AB 1979 on artificial intelligence in health care, AB 2161 on Medi-Cal work requirements, AB 539 on extending approved prior authorizations, AB 2311 on physician employment at public hospital districts, AB 1148 on banning phthalates and bisphenols in food packaging, AB 1825 on mental health offender reentry coordination, and AB 2282 on a temporary emergency stabilization unit in Patterson. AB 1979 would preserve licensed clinicians’ professional judgment, bar AI from directing unlicensed clinical functions, and protect medical records used by consumer chatbots; after amendments, several hospital, medical, and industry groups moved from opposition to neutral. AB 2161 would limit the harm of federal Medi-Cal work-reporting rules by using existing data, improving notices, and protecting due process; it drew broad support from patient, provider, and advocacy groups. AB 539 would keep prior authorization approvals valid for up to one year or the course of treatment, with supporters citing continuity of care and opponents warning about utilization, fraud, and cost concerns. AB 2311, as amended, would let certain high-payer-mix or distressed public health care districts directly employ physicians; CMA withdrew opposition after the bill was narrowed, while some hospital interests still objected to the carve-out. AB 1148 would prohibit two chemicals commonly used in food packaging, with supporters citing cancer and endocrine-disruption risks and opponents arguing DTSC should handle the issue through its existing regulatory process. AB 1825 would improve transition planning and Medi-Cal enrollment for offenders with mental health disorders leaving state hospitals, and AB 2282 would authorize a temporary rural emergency stabilization care unit in Patterson until a permanent hospital is built. Several bills were held for later action because the committee lacked a quorum, and the chair repeatedly noted that motions would be taken once enough members returned.
CT
Transcript Highlights:
  • receive that treatment.
  • That treatment.
  • Medication for addiction treatment is kind of another area that we want to make sure that programs are
  • So involvement in past treatment or current treatment is not an area of eligibility for this program
  • They can have that and still be a participant in this program, but it's not a requirement of the program
Keywords: 962, all
Summary: The meeting opened with approval of the April minutes and brief administrative updates, including notice that House Bill 5447 had passed both chambers of the General Assembly. Speakers reflected on the bill’s key provisions, which include eating-disorder working groups, an evidence-based screening requirement for school-based health centers beginning July 1, 2027, and a DSS-led feasibility process to explore an inpatient psychiatric facility for young adults ages 14 to 21. New staff introductions were also made for the Behavioral Health Advocate’s office and the TCB team. A major portion of the meeting focused on marketing and outreach for urgent crisis centers (UCCs) and the broader youth crisis continuum. Daydream Communications presented research showing low public awareness of UCCs but strong interest once families learn about them, with parents wanting specialized, compassionate care, clear expectations, insurance clarity, and bilingual support. United Way described its parallel work on a statewide crisis continuum marketing toolkit, using the SAMHSA framework of “someone to talk to, someone to respond, and somewhere safe to go,” and outlined plans to distribute consistent messaging through websites, social media, flyers, and community venues. Members emphasized coordinating with existing platforms and ensuring the marketing reflects the actual experience at UCC sites. DCF then presented on adolescent substance use services, citing data showing high need and low treatment access among Connecticut youth. The department reviewed its ASAM-based continuum, SBIRT efforts in outpatient psychiatric clinics, medication-assisted treatment access, and statewide services such as MST, MST emerging adults, STRIDE, multidimensional family therapy, youth recovery supports, and the AIM matching tool. A new young people peer support program was highlighted, with referrals accepted from families, hospitals, community providers, DCF, youth diversion, and the judicial branch. Questions addressed parent consent, peer matching, and whether the AIM tool could be linked through 211. The meeting concluded with an update from the Connecticut Suicide Advisory Board and its regional boards and grant-funded initiatives. Presenters reviewed the state suicide prevention plan, regional coalition work, postvention response, lethal means safety efforts, and the 988 capacity improvement grant that supports Connecticut’s centralized 988 contact center at United Way. They also shared youth suicide risk data from the Connecticut Youth Risk Behavior Survey, noting recent declines in reported suicidal ideation and attempts, and provided resources for training and materials. No formal votes were taken beyond the approval of the April minutes.